Ophthalmology Times
FORT LAUDERDALE, Fla. — Fewer intravitreal injections of ranibizumab were needed to treat patients with choroidal neovascularization secondary to age-related macular The use of green gold nanoparticles may have a place in the therapy of cancer and ophthalmic diseases because of the affinity of the gold nanoparticles for the leaky vasculature in those diseases, according to Kattesh Katti, PhD, from Nanotechnology, Physics, and Radiology, University of Missouri, Columbia.